Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma

Clinical trial NCT00482911 · TERMINATED

Trial details

NCT number: NCT00482911
Sponsor: National Institutes of Health Clinical Center (CC)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Intraocular Melanoma Malignant Conjunctival Neoplasm

Start date: 2007-04-01
Primary completion: 2009-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.